Evidence map›Paper›PMID 27626637›Full record

ArticlePloS one2016

Beyond Helper Phage: Using "Helper Cells" to Select Peptide Affinity Ligands.

M Lisa Phipps, Antoinetta M Lillo, Yulin Shou, Emily N Schmidt, Chad D Paavola, Leslie Naranjo, Sara Bemdich, Basil I Swanson, Andrew R M Bradbury, Jennifer S Martinez

Abstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Development of Anti-ImmunoTargets and therapy · 2020
    Article
  6. Article
  7. Naïve Human Antibody Libraries for Infectious Diseases.Advances in experimental medicine and biology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

M Lisa PhippsCenter for Integrated Nanotechnologies, Los Alamos National Laboratory, Los Alamos, NM 87545, United States of America.
Antoinetta M LilloBioscience Division, Los Alamos National Laboratory, Los Alamos, NM 87545, United States of America.
Yulin ShouBioscience Division, Los Alamos National Laboratory, Los Alamos, NM 87545, United States of America.
Emily N SchmidtBioscience Division, Los Alamos National Laboratory, Los Alamos, NM 87545, United States of America.
Chad D PaavolaSpace Biosciences Division, National Aeronautics and Space Administration Ames Research Center, Moffett Field, CA 94035, United States of America.
Leslie NaranjoBioscience Division, Los Alamos National Laboratory, Los Alamos, NM 87545, United States of America.
Sara BemdichBioscience Division, Los Alamos National Laboratory, Los Alamos, NM 87545, United States of America.
Basil I SwansonBioscience Division, Los Alamos National Laboratory, Los Alamos, NM 87545, United States of America.
Andrew R M BradburyBioscience Division, Los Alamos National Laboratory, Los Alamos, NM 87545, United States of America.
Jennifer S MartinezCenter for Integrated Nanotechnologies, Los Alamos National Laboratory, Los Alamos, NM 87545, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peptides are important affinity ligands for microscopy, biosensing, and targeted delivery. However, because they can have low affinity for their targets, their selection from large naïve libraries can be challenging. When selecting peptidic ligands from display libraries, it is important to: 1) ensure efficient display; 2) maximize the ability to select high affinity ligands; and 3) minimize the effect of the display context on binding. The "helper cell" packaging system has been described as a tool to produce filamentous phage particles based on phagemid constructs with varying display levels, while remaining free of helper phage contamination. Here we report on the first use of this system for peptide display, including the systematic characterization and optimization of helper cells, their inefficient use in antibody display and their use in creating and selecting from a set of phage display peptide libraries. Our libraries were analyzed with unprecedented precision by standard or deep sequencing, and shown to be superior in quality than commercial gold standards. Using our helper cell libraries, we have obtained ligands recognizing Yersinia pestis surface antigen F1V and L-glutamine-binding periplasmic protein QBP. In the latter case, unlike any of the peptide library selections described so far, we used a combination of phage and yeast display to select intriguing peptide ligands. Based on the success of our selections we believe that peptide libraries obtained with helper cells are not only suitable, but preferable to traditional phage display libraries for selection of peptidic ligands.

Indexed as

LigandsAntigens, BacterialBacteriophage M13Escherichia coliFlow CytometryPeptide LibraryPeptidesSaccharomyces cerevisiaeYersinia pestisAntigens, BacterialLigandsPeptide LibraryPeptides

Identifiers

PMID27626637
PMCPMC5023105

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.